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Alcohol is one of the most common substances abused in pregnancy. In the US, nearly half of all women in child‑bearing age have a history of alcohol intake in the 
past 1 month [1]. The prevalence of alcoholism in pregnancy varies 
from 7.6% to 30% [2]. Incidence of fetal alcohol syndrome (FAS) 
in the US is reported to be 1000 live births and affecting around 
2–5% of pre‑schoolers [3]. A recent meta‑analysis report lowers 
the prevalence of alcohol intake in pregnancy as well as fetal 
alcohol spectrum disorder (FASD) in southeast region (1.8%/100 
pregnancy and 2.7%/10,000 live births, respectively) as compared 
to rest of the world [4].
Although alcoholism in pregnancy is less common in Indian 
subcontinent, nevertheless with urbanization and better economy, 
it is gradually expanding like an epidemic which is worrisome. 
Exact incidence of alcohol intake in pregnancy as well as alcoholic 
spectrum disorder from our country is unknown. Only available 
WHO report (“Gender, Alcohol, and Culture: An International 
Study”) mentions the prevalence of 5.8% among Indian women [5]. 
Nevertheless, it is one of the preventable causes of congenital defect 
and developmental morbidity. Thus, in the current review, we tried 
to summarize briefly the clinical features and management aspects 
of FAS from the prospective of Indian subcontinent.
Definition
FASD is a broad terminology that is used to describe a group 
of phenotypes in an individual who has a history of exposure to 
alcohol in prenatal period in the womb of mother [6].




3. Alcohol‑related neurodevelopmental disorder
4. Neurobehavioral disorder associated with prenatal alcohol 
exposure sometimes called neurodevelopmental disorder 
associated with prenatal alcohol exposure
5. Alcohol‑related birth defects.
PATHOGENESIS
Alcohol is a teratogen that crosses placenta freely. Thus fetal 
level equalises with maternal levels within couple of hours 
of maternal intake. Elimination is dependent on the maternal 
metabolism in liver by alcohol dehydrogenase (ADH) enzyme. 
The expression of ADH gene allele varies from one pregnant 
woman to other resulting in variable degree of accumulation of 
alcohol in the body which subsequently crosses the placenta. It 
causes irreversible damage to central nervous system (CNS) and 
facial structures in early organogenesis phase (gastrulation and 
post‑gastrulation stages) [9]. Alcohol (ethanol) causes apoptotic 
cell death of neurons as well as epithelium destined to form future 
facial structures by dual mechanism, i.e., activation of GABA 
receptors and inhibition of NMDA receptors [10,11]. This results 
in several pathological findings in CNS such as reduced brain 
volume (especially of frontal lobe, striatum, caudate nucleus, 
thalamus, and cerebellum); thinning of the corpus callosum; 
and abnormal functioning of the amygdala. Similarly, the facial 
defects can be explained by the irreversible damage to the 
epithelial lining of future nasal cavity as well as commissural 
plate of telencephalon [12].
However, it is noteworthy that apart from early gestation, 
alcohol is notorious to affect fetus potentially at all gestational 
age [13‑15]. Selective exposure in the first trimester and early 
second trimester is associated with spontaneous abortion and 
major structural anomalies [15]. Though 3rd trimester exposure 
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results in universal growth restriction, neurobehavioral 
problems may happen with exposure to any stage. However, 
neurobehavioral problems may happen to an infant with a history 
of alcohol exposure at any stage of gestation.
It is worth mentioning that exact level of alcohol intake 
during pregnancy to cause FASD is unknown and varies from 
women to women. Some contributing factors are pattern of 
drinking (occasional/regular), amount of drink (heavy drinker 
or light drinker), genetic variation, difference in metabolism of 
alcohol in liver, and last but not the least variations of vulnerability 
of several regions of brain to alcohol toxicity.
PREVALENCE
Various studies have reported varied prevalence. In a recent 
meta‑analysis of 24 studies, the estimated global prevalence of 
FASD in the general population of children aged 0–16.4 years 
was 7.7/1000 population (95% CI 5–12/1000 population) [4]. 
The prevalence was highest (20/1000 population) in the WHO 
European region and lowest (0.1/1000 population) in the WHO 
Eastern Mediterranean region. However, the reported data can be 
truncated due to selective reporting and restricted reporting from 
the regions where alcoholism is regarded as a social stigma.
Various maternal risk factors associated with antenatal alcohol 
consumption include positive history of alcoholism in the family, 
low educational level, higher maternal age, higher gravity, and 
poor maternal nutrition. The reported prevalence of alcoholism 
among Indian women as noted by the WHO is 5.8% in general 
population [5]. However, it is more prevalent among women 
from lower socioeconomic status, tribal women working in tea 
plantation, and commercial sex workers with recent upsurge in 
women from upper economic classes where it is counted as status 
symbol. The reported prevalence in these high‑risk groups is as 
high as 28–48% [16].
CLINICAL FEATURES
The three classic facial features of FASD are short palpebral 
fissures, thin vermillion border, and smooth philtrum (Fig. 1). The 
presence of combinations of these facial features differentiates 
FAS from normal population with almost certainty. Other common 
facial anomalies include hypoplastic midface, epicanthal folds, 
flat nasal bridge, palmar abnormalities (altered paler creases, 
5th finger clinodactyly, and camptodactyly), decreased intercanthal 
distance, ptosis, and strabismus ear anomalies [17‑19].
Other less common but not so rare systemic involvement 
includes cardiac (atrial septal defect/ventricular septal 
defect and conotruncal), skeletal (joint contractures, pectus 
excavatum, and hemivertebrae), renal (aplasia and hypoplasia), 
ocular (strabismus and optic nerve hypoplasia visual problem), 
and auditory (conductive defect).
CNS involvement [20‑22] could be structural such as 
microcephaly, decrease brain matter in imaging, or only 
neurologic abnormalities on clinical examination such as 
abnormal reflex and tone. More commonly, it can have only 
functional abnormalities such as irritability, jitteriness, autonomic 
instability in infancy, hyperactivity, inattention, poor cognitive 
performance, language delay in childhood period and poor social 
skills, and executive function in adulthood. Many of them have 
associated comorbid mental problems such as sleep disorders, 
anxiety, adjustment disorders, eating disorders, and impulsive 
behavior. They themselves are more vulnerable to fall into track 
of alcoholism and other substances abuse later in the life. Prenatal 
as well as postnatal growth retardations are one of the diagnostic 
features of FASD. Growth failure and short stature extend well 
into adulthood.
In recent case–control study from India by Nayak et al., it 
was concluded that children with FAS are more likely to have 
mild physical anomalies and ADHD (nearly 40%) as compared 
to their normal counterpart [23]. This was in contrast to the 
previously reported study from other parts of world, where there 
was not much difference in anthropometry as well as facial 
parameters (with exception being philtrum smoothness) among 
cases and controls. This could be attributed to higher prevalence 
of underlying malnutrition in both the groups [23].
IMAGING
The salient feature of magnetic neuroimaging of brain of affected 
children includes varying degree of decrease in overall size of 
brain, especially that of basal ganglia, hippocampus, corpus 
callosum, and cerebellum.
DIAGNOSIS
Diagnosis of FASD is purely clinically depending on the 
presence of structural defects, functional neurological deficits. 
The diagnosis is mentioned below in tabular format [Table 1] as 
below.
A detailed toolkit comprising flow diagram, checklist, 
and answer to frequently asked questions related to FASD is 
available on AAP website [25]. The toolkit has been developed 
with purpose of raising awareness, promotion of surveillance 
and screening, and for ensuring timely intervention of all 
affected children. The website assists in proactive developmental 
surveillance for the presence of signs and symptoms of FAS by 
Figure 1: Classic facial features of fetal alcohol syndrome
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health‑care professionals for early diagnosis and management 
by home visit or at community health facilities. It emphasizes 
on the presence of certain clinical features such as the presence 
of growth retardation (height or weight below 10th centile as per 
age), short palpebral fissures, thin upper lip, CNS anomalies, 
smooth philtrum, and presence of a history of alcohol abuse in 
mother during pregnancy for picking up cases in surveillance. 
Such suspected cases are referred to higher center for detailed 
neurological evaluation by experts and initiation of early 
rehabilitation.
MANAGEMENT AND PROGNOSIS
Management comprises detailed assessment for diagnosis and 
interventions. Detailed assessment includes evaluation of degree 
of physical deficit, IQ testing, screening of learning disability, 
assessment of neurocognitive functioning, neuroimaging, and 
functional abilities. Treatment of FASD is difficult and most 
of the time only supportive therapy is advised. Recent clinical 
trial has shown some preventive role of choline supplementation 
in cognitive deficit [26]. For children who are already affected 
by FASD, some of the targeted areas of intervention depending 
on the degree of involvement are as follows: (1) Visual 
rehabilitation; (2) environmental modification; (3) organization 
of specific tasks; (4) physiotherapy; (5) cognitive‑behavioral 
therapy; and (6) building of support system by family as 
well as society. Specific medical/neurological or behavioral 
problems identified by detailed examination should be addressed 
individually as per existing guidelines for that particular problem.
In the absence of definitive treatment for FASD, primary 
preventive strategy remains mainstay of therapy at present. 
Counseling of the family for the prevention of recurrence in 
future pregnancy is utmost important. As there is no clearly safe 
limits (in terms of duration, amount and frequency of alcohol 
consumption) for prevention of FASD, full abstinence during 
pregnancy from alcohol is the only guard proof solution. As 
organogenesis happens in the first trimester and early second 
trimester, it is advisable that women should give up alcohol before 
planning pregnancy itself. Supplementation of deficient nutrients 
in pregnancy such as retinoids, folic acid choline, B‑complex, and 
Vitamin E may have a role.
CONCLUSION
FASD is one of the preventable causes of neurodeficits and 
behavioral problems. As alcoholism is regarded as a social 
stigma/taboo in India, such history is rarely revealed by pregnant 
women in antenatal clinic. Hence, utmost effects should be made 
for eliciting these facts among pregnant ladies in antenatal clinic, 
especially in high‑risk group. Upon finding such history, it is 
advisable to follow full abstinence throughout pregnancy as the 
safe level of alcohol intake is unknown.
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FAS: Fetal alcohol syndrome, CNS: Central nervous system
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